Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 14, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

January 1, 2026

Conditions
Major Depression
Interventions
DEVICE

HD ctACS

Participants received High-Definition closed-loop transcranial Alternating Current Stimulation (HD-ctACS) for 30 minutes daily, 5 days per week. A 4x1 ring electrode montage was used, with the center electrode placed over the bilateral temporal cortices. Stimulation was delivered as a sinusoidal alternating current at a 2 mA peak amplitude, with the frequency individualized for each participant based on their baseline EEG. The stimulation was administered in a closed-loop, task-specific manner: a 500 ms burst of stimulation was triggered only when a subliminal negative facial stimulus was presented and the participant's real-time Nucleus Accumbens gamma power exceeded their baseline by two standard deviations.

DEVICE

HD ctACS sham

Participants received High-Definition transcranial Alternating Current Stimulation (HD-tACS) in 30-minute sessions once daily, 5 days per week. A 4x1 ring electrode layout was used to target the bilateral temporal cortices. The stimulation consisted of a sinusoidal alternating current with a 2 mA peak intensity, delivered at an individualized gamma frequency determined from a baseline EEG. The intervention was administered using a closed-loop, task-specific paradigm: upon presentation of a subliminal negative facial stimulus while the real-time Nucleus Accumbens gamma power exceeded a baseline threshold of +2 SD, a 500 ms stimulation was delivered following a random delay of 1000-2000 ms.

Trial Locations (1)

200025

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER